Literature DB >> 2848083

Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum.

J R Mohammed1, B S Mohammed, L J Pawluk, D M Bucci, N R Baker, W B Davis.   

Abstract

The neutrophil myeloperoxidase-H2O2-halide enzyme system produces hypochlorous acid and chlorinated amine compounds capable of killing a variety of target cells. In the present study we hypothesized that the myeloperoxidase enzyme system is one mechanism for airway epithelial damage in patients with cystic fibrosis (CF). Enzyme linked immunosorbent assay detected high antigenic levels of myeloperoxidase in sputum samples of seven patients with CF. Myeloperoxidase was purified to homogeneity from CF sputum and from blood neutrophils by a three-step technique involving dialysis, gel filtration, and ion-exchange chromatography. CF sputum myeloperoxidase and neutrophil myeloperoxidase appeared identical by acid gel electrophoresis and Ouchterlony experiments. CF sputum myeloperoxidase also contained approximately the same enzymatic activity as neutrophil myeloperoxidase. The myeloperoxidase enzyme system was tested for its cytotoxic potential in a tracheal ring culture system. Myeloperoxidase-induced cytotoxicity for airway epithelium was confirmed by light microscopy and radiolabelling experiments. These findings suggest a possible role for neutrophil myeloperoxidase in CF lung disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848083

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  16 in total

1.  Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor.

Authors:  J Kadota; T Iwashita; Y Matsubara; Y Ishimatsu; M Yoshinaga; K Abe; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 2.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Relationship between disease severity and inflammatory markers in cystic fibrosis.

Authors:  D Y Koller; M Götz; C Wojnarowski; I Eichler
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

4.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

5.  Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.

Authors:  B E Britigan; B L Edeker
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

6.  Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation.

Authors:  R A Miller; B E Britigan
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

7.  Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.

Authors:  A Cantin; D E Woods
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation.

Authors:  R A Miller; G T Rasmussen; C D Cox; B E Britigan
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.

Authors:  T Fujii; J Kadota; K Kawakami; K Iida; R Shirai; M Kaseda; S Kawamoto; S Kohno
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

10.  Eosinophilic activation in cystic fibrosis.

Authors:  D Y Koller; M Götz; I Eichler; R Urbanek
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.